{
    "paper_id": "d346879836cf3a44a0cb14cc63f65d5180a11641",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [
        {
            "text": "publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. ADVANCES IN VIRUS RESEARCH, VOL. 49 INDEX Boldface numerals indicate volume numbers A 2'-5'A analogs, antiviral activities, viral mRNA degradation, 30121 30120-123 AAV, see Adeno-associated virus AAV-2, human herpesvirus 6 and, 41:18 Abaca bunchy top virus, 33:309-310 Abelson disease carboxy terminus, 35:72 lymphoid differentiation, 3574 mutations within protein tyrosine kinase-conserved region, 35:73-74 pathology, 3542-43 cell transformation by, 2688-90 conditional transformation mutants, 35:72-73 early research, 3540-41 genetics, 3567-75 Abelson murine leukemia virus Ab-MLV-P16O VS. Ab-MLV-P120, 3570-71 carboxy terminus, 3571-72 conserved regions, 3568-69 gag sequences, 3569-70 lymphoid transformation, 3569 MoMLV, 35:67 hematopoietic transformation, 3555-67 B lymphopoiesis, 3555-57 establishment and progression of Ig gene structure, 3557-58 interaction with hematopoietic linlymphoid differentiation markers, transformant and target cell, 35:50-transformed state, 3563-67 eages, 3562-63 3 5 5 -6 0 62 in uitro transformation of lymphoid cells, 3544-45 Ig gene structure, 35:57-58 lymphoid differentiation markers, 3558-60 isolation, 3541-42 oncogene structure activation of transforming potential, molecular cloning, 3550-51 protein expression, 3546-50 splicing patterns, 35:51-53 3553-55 3T3 cells in uitro, 35:43-44",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "origin , to bacteria, anti-isotypic, 35:233-234 to paramyxoviridae, 3k229-231 rotaviruses and, 36182, 39182-183, 187-190 neutralization, 36183-187, 192-194, protection, 36188-190 surface proteins, 36202-204, 206-198, 201 207 rotavirus-specific, 44:170-172 Sindbis virus encephalitis and, 36258 synthetic peptides, reaction with influenza virus hemagglutinin, 31:73-74 Theiler's murine encephalomyelitis virus and, 39:293-295,305, 307,309 vaccinia and, 3457-58 mice, 41:106, 110, [116] [117] [118] [249] [250] [251] 278, [280] [281] [282] [283] 41:152 141 123 lentiviruses and structure, 198 virus-host cell interaction in uiuo, MATSA , 39183, 186, 198 300,303-305 neutralization, 36186, 192-195, protection, 36190 surface proteins, 36203-204 198-199,201 Sindbis virus encephalitis and, 36:258- , 182-186, 191-192 29:171, 177-182,186,190-193 , 36183, 192-195, 198, and, 41:353, 382 200-202,39180, 195 comparison mice, 41:111, 113, 115, 124 molecular properties, 41:150, 152oral vaccination, 41:410-412, 423, 426, pestiviruses, 41:67, 74-75, 80, 85 rotaviruses, 36:207; 39167, 171, 197 139 153 437-438 domains, 36:191-202 protection, 36190-191 protein, 36183-187 studies, 39181-184, 186 surface proteins, 36202-204, 206vaccination, 39187-190 , 174-176, 178, 180, 184-186, 195-197 viruses, 41:194, 196-197 readthrough suppression, 41:197ribosomal frameshifting, 41:211-203, 205,207-209 212,214,219-223, 229- Polyacrylamide gel electrophoresis ADRV, [197] [198] [200] [201] [202] 41:286, 288 picornaviruses, purification, 25:376-379 rabies viruses, 36:223, 240 rotaviruses, 36:181-183, 207; 39:166, 45:96-98 101, 180-182 tein 198 function, 36:204-207 neutralization, 36183-187, 191-192, protection, 36:187-191 reassortment, 39167, 169, 171-172 studies, 39177-178, 180, 183-186 surface, 36:202-204 vaccination, 39187-190 198-199 in viruses, 41:194, 196, 233 cis-acting sequences, 41:219, 223 frameshift site, 41:216-217 readthrough suppression, 41:198ribosomal frameshifting, 41:210-200,204-207,210 212, 230-231,233 vaccinia, 3444, 61 genome, 3447-49 vector, 3450, 57- 40182animals and humans, 40189-191, plants, 40198-199, 202, 205-206 263-264,267 115-117, 119-120 lentiviruses 34196-197, 199-200 34200,202, 207 luteoviruses, 46449- , 41:4, 35 lentiviruses, 34:192, 194, 198 torovirus, polymerase chain reaction amplification, 43265 translational suppression by retroviruses, 41:194, 197, 205, 211, 231 ) translational suppression by retroviruses, 41:196-197, 202, 210- 40189-194, 197-198 plant, 40:198-206 183, 185-187, 189 dianthoviruses, properties, 33:266-268 DNA replication, 34:ll double-stranded, see 3635, [88] [89] [90] 92 insertional mutagenesis, intracellular cycles, 3660, [62] [63] [64] organization, [53] [54] 56, transcription, 74 , 43:189-190, 196-197 binding, 43:216 cleavage and ligation, 43:194 directed synthesis, 43:195 editing, 43:195, 206-207 species, 43:198-199 hepatitis E virus, 4058, 87, 89-90, 93 -1, 402, 6-8, 10, 12, 14 components, 34:248-249, 252-253, genetic reassortment, 34:257 pathogenicity, 34:264 killed antiviral vaccines, 39265, 282 lentiviruses structure, 34:191-192, 194-195 virus-host cell , lentiviruses, 34192 rotaviruses, 36182, 198; [197] [198] [199] genome, readthrough suppression, 41: 198, ribosomal frameshifting, 41:212, viruses, 41:194, 233 200, 202, 204, [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] 42:94 vaccinia, 3444, [60] [61] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] 3450, [55] [56] [57] retroviruses, 233 readthrough, 210 alternate stop codons, -167, 173-174, 178-182, 184-189, 192, 194-195, 197-198 ",
            "cite_spans": [
                {
                    "start": 12,
                    "end": 255,
                    "text": "bacteria, anti-isotypic, 35:233-234 to paramyxoviridae, 3k229-231 rotaviruses and, 36182, 39182-183, 187-190 neutralization, 36183-187, 192-194, protection, 36188-190 surface proteins, 36202-204, 206-198, 201 207 rotavirus-specific, 44:170-172",
                    "ref_id": null
                },
                {
                    "start": 403,
                    "end": 459,
                    "text": "virus and, 39:293-295,305, 307,309 vaccinia and, 3457-58",
                    "ref_id": null
                },
                {
                    "start": 460,
                    "end": 465,
                    "text": "mice,",
                    "ref_id": null
                },
                {
                    "start": 466,
                    "end": 473,
                    "text": "41:106,",
                    "ref_id": null
                },
                {
                    "start": 474,
                    "end": 478,
                    "text": "110,",
                    "ref_id": null
                },
                {
                    "start": 479,
                    "end": 484,
                    "text": "[116]",
                    "ref_id": null
                },
                {
                    "start": 485,
                    "end": 490,
                    "text": "[117]",
                    "ref_id": null
                },
                {
                    "start": 491,
                    "end": 496,
                    "text": "[118]",
                    "ref_id": null
                },
                {
                    "start": 497,
                    "end": 502,
                    "text": "[249]",
                    "ref_id": null
                },
                {
                    "start": 503,
                    "end": 508,
                    "text": "[250]",
                    "ref_id": null
                },
                {
                    "start": 509,
                    "end": 514,
                    "text": "[251]",
                    "ref_id": null
                },
                {
                    "start": 515,
                    "end": 519,
                    "text": "278,",
                    "ref_id": null
                },
                {
                    "start": 520,
                    "end": 525,
                    "text": "[280]",
                    "ref_id": null
                },
                {
                    "start": 526,
                    "end": 531,
                    "text": "[281]",
                    "ref_id": null
                },
                {
                    "start": 532,
                    "end": 537,
                    "text": "[282]",
                    "ref_id": null
                },
                {
                    "start": 538,
                    "end": 543,
                    "text": "[283]",
                    "ref_id": null
                },
                {
                    "start": 544,
                    "end": 586,
                    "text": "41:152 141 123 lentiviruses and structure,",
                    "ref_id": null
                },
                {
                    "start": 587,
                    "end": 590,
                    "text": "198",
                    "ref_id": null
                },
                {
                    "start": 628,
                    "end": 633,
                    "text": "MATSA",
                    "ref_id": null
                },
                {
                    "start": 634,
                    "end": 753,
                    "text": ", 39183, 186, 198 300,303-305 neutralization, 36186, 192-195, protection, 36190 surface proteins, 36203-204 198-199,201",
                    "ref_id": null
                },
                {
                    "start": 794,
                    "end": 840,
                    "text": ", 182-186, 191-192 29:171, 177-182,186,190-193",
                    "ref_id": null
                },
                {
                    "start": 841,
                    "end": 910,
                    "text": ", 36183, 192-195, 198, and, 41:353, 382 200-202,39180, 195 comparison",
                    "ref_id": null
                },
                {
                    "start": 911,
                    "end": 1239,
                    "text": "mice, 41:111, 113, 115, 124 molecular properties, 41:150, 152oral vaccination, 41:410-412, 423, 426, pestiviruses, 41:67, 74-75, 80, 85 rotaviruses, 36:207; 39167, 171, 197 139 153 437-438 domains, 36:191-202 protection, 36190-191 protein, 36183-187 studies, 39181-184, 186 surface proteins, 36202-204, 206vaccination, 39187-190",
                    "ref_id": null
                },
                {
                    "start": 1240,
                    "end": 1277,
                    "text": ", 174-176, 178, 180, 184-186, 195-197",
                    "ref_id": null
                },
                {
                    "start": 1278,
                    "end": 1404,
                    "text": "viruses, 41:194, 196-197 readthrough suppression, 41:197ribosomal frameshifting, 41:211-203, 205,207-209 212,214,219-223, 229-",
                    "ref_id": null
                },
                {
                    "start": 1440,
                    "end": 1445,
                    "text": "ADRV,",
                    "ref_id": null
                },
                {
                    "start": 1446,
                    "end": 1451,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 1452,
                    "end": 1457,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 1458,
                    "end": 1463,
                    "text": "[200]",
                    "ref_id": null
                },
                {
                    "start": 1464,
                    "end": 1469,
                    "text": "[201]",
                    "ref_id": null
                },
                {
                    "start": 1470,
                    "end": 1475,
                    "text": "[202]",
                    "ref_id": null
                },
                {
                    "start": 1476,
                    "end": 1483,
                    "text": "41:286,",
                    "ref_id": null
                },
                {
                    "start": 1484,
                    "end": 1503,
                    "text": "288 picornaviruses,",
                    "ref_id": null
                },
                {
                    "start": 1504,
                    "end": 1823,
                    "text": "purification, 25:376-379 rabies viruses, 36:223, 240 rotaviruses, 36:181-183, 207; 39:166, 45:96-98 101, 180-182 tein 198 function, 36:204-207 neutralization, 36183-187, 191-192, protection, 36:187-191 reassortment, 39167, 169, 171-172 studies, 39177-178, 180, 183-186 surface, 36:202-204 vaccination, 39187-190 198-199",
                    "ref_id": null
                },
                {
                    "start": 1827,
                    "end": 2063,
                    "text": "viruses, 41:194, 196, 233 cis-acting sequences, 41:219, 223 frameshift site, 41:216-217 readthrough suppression, 41:198ribosomal frameshifting, 41:210-200,204-207,210 212, 230-231,233 vaccinia, 3444, 61 genome, 3447-49 vector, 3450, 57-",
                    "ref_id": null
                },
                {
                    "start": 2064,
                    "end": 2131,
                    "text": "40182animals and humans, 40189-191, plants, 40198-199, 202, 205-206",
                    "ref_id": null
                },
                {
                    "start": 2132,
                    "end": 2228,
                    "text": "263-264,267 115-117, 119-120 lentiviruses 34196-197, 199-200 34200,202, 207 luteoviruses, 46449-",
                    "ref_id": null
                },
                {
                    "start": 2229,
                    "end": 2270,
                    "text": ", 41:4, 35 lentiviruses, 34:192, 194, 198",
                    "ref_id": null
                },
                {
                    "start": 2358,
                    "end": 2398,
                    "text": "retroviruses, 41:194, 197, 205, 211, 231",
                    "ref_id": null
                },
                {
                    "start": 2399,
                    "end": 2400,
                    "text": ")",
                    "ref_id": null
                },
                {
                    "start": 2430,
                    "end": 2465,
                    "text": "retroviruses, 41:196-197, 202, 210-",
                    "ref_id": null
                },
                {
                    "start": 2466,
                    "end": 2559,
                    "text": "40189-194, 197-198 plant, 40:198-206 183, 185-187, 189 dianthoviruses, properties, 33:266-268",
                    "ref_id": null
                },
                {
                    "start": 2604,
                    "end": 2609,
                    "text": "3635,",
                    "ref_id": null
                },
                {
                    "start": 2610,
                    "end": 2614,
                    "text": "[88]",
                    "ref_id": null
                },
                {
                    "start": 2615,
                    "end": 2619,
                    "text": "[89]",
                    "ref_id": null
                },
                {
                    "start": 2620,
                    "end": 2624,
                    "text": "[90]",
                    "ref_id": null
                },
                {
                    "start": 2625,
                    "end": 2652,
                    "text": "92 insertional mutagenesis,",
                    "ref_id": null
                },
                {
                    "start": 2653,
                    "end": 2674,
                    "text": "intracellular cycles,",
                    "ref_id": null
                },
                {
                    "start": 2675,
                    "end": 2680,
                    "text": "3660,",
                    "ref_id": null
                },
                {
                    "start": 2681,
                    "end": 2685,
                    "text": "[62]",
                    "ref_id": null
                },
                {
                    "start": 2686,
                    "end": 2690,
                    "text": "[63]",
                    "ref_id": null
                },
                {
                    "start": 2691,
                    "end": 2695,
                    "text": "[64]",
                    "ref_id": null
                },
                {
                    "start": 2696,
                    "end": 2709,
                    "text": "organization,",
                    "ref_id": null
                },
                {
                    "start": 2710,
                    "end": 2714,
                    "text": "[53]",
                    "ref_id": null
                },
                {
                    "start": 2715,
                    "end": 2719,
                    "text": "[54]",
                    "ref_id": null
                },
                {
                    "start": 2720,
                    "end": 2723,
                    "text": "56,",
                    "ref_id": null
                },
                {
                    "start": 2724,
                    "end": 2738,
                    "text": "transcription,",
                    "ref_id": null
                },
                {
                    "start": 2739,
                    "end": 2741,
                    "text": "74",
                    "ref_id": null
                },
                {
                    "start": 2742,
                    "end": 2920,
                    "text": ", 43:189-190, 196-197 binding, 43:216 cleavage and ligation, 43:194 directed synthesis, 43:195 editing, 43:195, 206-207 species, 43:198-199 hepatitis E virus, 4058, 87, 89-90, 93",
                    "ref_id": null
                },
                {
                    "start": 2921,
                    "end": 3127,
                    "text": "-1, 402, 6-8, 10, 12, 14 components, 34:248-249, 252-253, genetic reassortment, 34:257 pathogenicity, 34:264 killed antiviral vaccines, 39265, 282 lentiviruses structure, 34:191-192, 194-195 virus-host cell",
                    "ref_id": null
                },
                {
                    "start": 3128,
                    "end": 3129,
                    "text": ",",
                    "ref_id": null
                },
                {
                    "start": 3130,
                    "end": 3143,
                    "text": "lentiviruses,",
                    "ref_id": null
                },
                {
                    "start": 3144,
                    "end": 3162,
                    "text": "34192 rotaviruses,",
                    "ref_id": null
                },
                {
                    "start": 3163,
                    "end": 3169,
                    "text": "36182,",
                    "ref_id": null
                },
                {
                    "start": 3170,
                    "end": 3174,
                    "text": "198;",
                    "ref_id": null
                },
                {
                    "start": 3175,
                    "end": 3180,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 3181,
                    "end": 3186,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 3187,
                    "end": 3192,
                    "text": "[199]",
                    "ref_id": null
                },
                {
                    "start": 3193,
                    "end": 3200,
                    "text": "genome,",
                    "ref_id": null
                },
                {
                    "start": 3201,
                    "end": 3225,
                    "text": "readthrough suppression,",
                    "ref_id": null
                },
                {
                    "start": 3226,
                    "end": 3234,
                    "text": "41: 198,",
                    "ref_id": null
                },
                {
                    "start": 3235,
                    "end": 3259,
                    "text": "ribosomal frameshifting,",
                    "ref_id": null
                },
                {
                    "start": 3260,
                    "end": 3267,
                    "text": "41:212,",
                    "ref_id": null
                },
                {
                    "start": 3268,
                    "end": 3276,
                    "text": "viruses,",
                    "ref_id": null
                },
                {
                    "start": 3277,
                    "end": 3284,
                    "text": "41:194,",
                    "ref_id": null
                },
                {
                    "start": 3285,
                    "end": 3293,
                    "text": "233 200,",
                    "ref_id": null
                },
                {
                    "start": 3294,
                    "end": 3298,
                    "text": "202,",
                    "ref_id": null
                },
                {
                    "start": 3299,
                    "end": 3303,
                    "text": "204,",
                    "ref_id": null
                },
                {
                    "start": 3304,
                    "end": 3309,
                    "text": "[207]",
                    "ref_id": null
                },
                {
                    "start": 3310,
                    "end": 3315,
                    "text": "[208]",
                    "ref_id": null
                },
                {
                    "start": 3316,
                    "end": 3321,
                    "text": "[209]",
                    "ref_id": null
                },
                {
                    "start": 3322,
                    "end": 3327,
                    "text": "[210]",
                    "ref_id": null
                },
                {
                    "start": 3328,
                    "end": 3333,
                    "text": "[211]",
                    "ref_id": null
                },
                {
                    "start": 3334,
                    "end": 3339,
                    "text": "[212]",
                    "ref_id": null
                },
                {
                    "start": 3340,
                    "end": 3345,
                    "text": "[213]",
                    "ref_id": null
                },
                {
                    "start": 3346,
                    "end": 3351,
                    "text": "[214]",
                    "ref_id": null
                },
                {
                    "start": 3352,
                    "end": 3357,
                    "text": "[215]",
                    "ref_id": null
                },
                {
                    "start": 3358,
                    "end": 3363,
                    "text": "[216]",
                    "ref_id": null
                },
                {
                    "start": 3364,
                    "end": 3369,
                    "text": "[217]",
                    "ref_id": null
                },
                {
                    "start": 3370,
                    "end": 3375,
                    "text": "[218]",
                    "ref_id": null
                },
                {
                    "start": 3376,
                    "end": 3381,
                    "text": "[219]",
                    "ref_id": null
                },
                {
                    "start": 3382,
                    "end": 3387,
                    "text": "[220]",
                    "ref_id": null
                },
                {
                    "start": 3388,
                    "end": 3393,
                    "text": "[221]",
                    "ref_id": null
                },
                {
                    "start": 3394,
                    "end": 3399,
                    "text": "[222]",
                    "ref_id": null
                },
                {
                    "start": 3400,
                    "end": 3405,
                    "text": "[223]",
                    "ref_id": null
                },
                {
                    "start": 3406,
                    "end": 3411,
                    "text": "[224]",
                    "ref_id": null
                },
                {
                    "start": 3412,
                    "end": 3427,
                    "text": "42:94 vaccinia,",
                    "ref_id": null
                },
                {
                    "start": 3428,
                    "end": 3433,
                    "text": "3444,",
                    "ref_id": null
                },
                {
                    "start": 3434,
                    "end": 3438,
                    "text": "[60]",
                    "ref_id": null
                },
                {
                    "start": 3439,
                    "end": 3443,
                    "text": "[61]",
                    "ref_id": null
                },
                {
                    "start": 3444,
                    "end": 3448,
                    "text": "[34]",
                    "ref_id": null
                },
                {
                    "start": 3449,
                    "end": 3453,
                    "text": "[35]",
                    "ref_id": null
                },
                {
                    "start": 3454,
                    "end": 3458,
                    "text": "[36]",
                    "ref_id": null
                },
                {
                    "start": 3459,
                    "end": 3463,
                    "text": "[37]",
                    "ref_id": null
                },
                {
                    "start": 3464,
                    "end": 3468,
                    "text": "[38]",
                    "ref_id": null
                },
                {
                    "start": 3469,
                    "end": 3473,
                    "text": "[39]",
                    "ref_id": null
                },
                {
                    "start": 3474,
                    "end": 3478,
                    "text": "[40]",
                    "ref_id": null
                },
                {
                    "start": 3479,
                    "end": 3483,
                    "text": "[41]",
                    "ref_id": null
                },
                {
                    "start": 3484,
                    "end": 3488,
                    "text": "[42]",
                    "ref_id": null
                },
                {
                    "start": 3489,
                    "end": 3493,
                    "text": "[43]",
                    "ref_id": null
                },
                {
                    "start": 3494,
                    "end": 3498,
                    "text": "[44]",
                    "ref_id": null
                },
                {
                    "start": 3499,
                    "end": 3503,
                    "text": "[45]",
                    "ref_id": null
                },
                {
                    "start": 3504,
                    "end": 3508,
                    "text": "[46]",
                    "ref_id": null
                },
                {
                    "start": 3509,
                    "end": 3513,
                    "text": "[47]",
                    "ref_id": null
                },
                {
                    "start": 3514,
                    "end": 3518,
                    "text": "[48]",
                    "ref_id": null
                },
                {
                    "start": 3519,
                    "end": 3523,
                    "text": "[49]",
                    "ref_id": null
                },
                {
                    "start": 3524,
                    "end": 3529,
                    "text": "3450,",
                    "ref_id": null
                },
                {
                    "start": 3530,
                    "end": 3534,
                    "text": "[55]",
                    "ref_id": null
                },
                {
                    "start": 3535,
                    "end": 3539,
                    "text": "[56]",
                    "ref_id": null
                },
                {
                    "start": 3540,
                    "end": 3544,
                    "text": "[57]",
                    "ref_id": null
                },
                {
                    "start": 3545,
                    "end": 3558,
                    "text": "retroviruses,",
                    "ref_id": null
                },
                {
                    "start": 3559,
                    "end": 3575,
                    "text": "233 readthrough,",
                    "ref_id": null
                },
                {
                    "start": 3576,
                    "end": 3602,
                    "text": "210 alternate stop codons,",
                    "ref_id": null
                },
                {
                    "start": 3603,
                    "end": 3657,
                    "text": "-167, 173-174, 178-182, 184-189, 192, 194-195, 197-198",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "methionine deprivation",
            "authors": [],
            "year": null,
            "venue": "CPE(+) and CPE(-) clones of Aedes albopictus cells",
            "volume": "33",
            "issn": "",
            "pages": "331--332",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "36199 structure, 28224-230 translational suppression by retroviruses",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "41",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "weanling mice",
            "authors": [],
            "year": null,
            "venue": "Sindbis virus encephalitis",
            "volume": "36",
            "issn": "",
            "pages": "36261--266",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Single-stranded RNA BMV CAT gene insertion and expression, deletion analysis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "32",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Single-stranded RNA viruses of plants",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "47",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "lesions diagnosis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "42",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Skunk, rabies viruses",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "36216",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "72-Small isometric virus, insect, morphol-74 ogy",
            "authors": [],
            "year": null,
            "venue": "Slow viruses, tissue tropisms of",
            "volume": "26",
            "issn": "",
            "pages": "25285--286",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "RNA properties, 25316-317 serological properties, 25340-341 structural proteins",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "331--333",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Smut killer system",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "43356--360",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Sobemo-like virus supergroup replication proteins, 47:199 sequences required for subgenomic RNA synthesis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "47",
            "issn": "",
            "pages": "229--230",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "MAb-determined antigenic properties",
            "authors": [],
            "year": null,
            "venue": "Sobemo viruses 145",
            "volume": "29",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Bromo-2'-deoxyuridine, DNA replication by parvovirus and, 33:",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fluorescent-activated cell sorter, 29:144 Fluorescent antibody, chickenpox-virus, induced membrane antigen, 28316-317 3'-Fluoro-3'-deoxyadenosine, 42:9-10 2'-Fluoro-2'-deoxy-5-iodo-l~-~-arabinosylcytosine anti-herpes, clinical trial, 30127 antiviral activity, 30:102-103 5-Fluorodeoxyuridine, 35290 3'-Fluoro-2',3 '-dideoxynucleosides, 42:28 (RS)-9-(3-Fluoro-2-phosphonylmethoxy-",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "modulation by sequences HIV-1, 44:31-32 in U3, 44:29-31",
            "latex": null,
            "type": "figure"
        },
        "TABREF3": {
            "text": "Bcr gene, Ab-MLV and, 3554-55 BCTV, see Beet curly top virus Bean-BCMV interrelations, genetics and, Bean common mosaic virus, in develop-Bee chronic paralysis virus group (cont. I Beet cryptic virus, mixture of two vi-Beet ringspot virus, Plantago hosts and Beet soil-borne virus, furoviruses and, Beet western yellows virus, 29152, Beet yellows closterovirus, ORFs, 47196 Beet yellow stunt virus, 25105 Npro gene, duplicated, protein pro-",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Uukuuirus genus, proposed serological viral morphologies and structural com-cal classification of, 31:33 receptor function, 31:374-375 Cell fusion, pathology and, 25239-241 Cell-infecting unit, 25251-253 Cell lines, see also Lymphoblastoid cell BHK, see Baby hamster kidney cells chicken embryo, influenza virus and, Cicadulina spp., see Leafhopper Circulifer tenellus, see Leafhopper Circumsporozoite antigens, oral vaccina-Plantago host and occurrence, 27:114,",
            "latex": null,
            "type": "table"
        },
        "TABREF5": {
            "text": "E3 promoter, in trans-activation of tran-hepatitis C virus and, 4063 hepatitis E virus and, 4088-90 ETEC, oral vaccination and, 41:",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "Fescue cryptic virus, mixture of two vi-",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": "Fos complex in signal transduction, with-Fowl plague virus, influenza virus and, Fox, rabies viruses and, 36216 mouse a-globin, effect on HSV-TK mRNAs, late, synthesis, in HSV repli-Glycoprotein I, varicella zoster virus, Glycoprotein 11, varicella zoster virus, Glycoprotein 111, varicella zoster virus, Glycoprotein IV, varicella zoster virus, Hematopoietic transformation, Ab-MLV Hemodialysis, hepadnavirus and, 34:132, Hemolysin, oral vaccination and, 41:415 Hemolysin inhibition, 2999 Hemolysis HEF glycoprotein of influenza C virus minus strand DNA priming and synplus strand DNA priming and synpregenomic RNA organization, RNA, encapsidation RNA packaging, U54-55 splicing, 4422 study with MAbs, 29102 binding to transcription factors, essential and dispensable domains functional trans-activator domain, interaction with cellular proteins un-packaging into sAg particles, 43:217pathogenesis and hepadnavirus suppost-translational modifications, role of amino acids unique to SAg-L, 43:2 18-2 19 self-litigation reaction, 43204 size, 43195-196 structure and replication, 43:189-191 studies in uitro, 43:194-195 suppression of hepadnavirus replication, 43:222-223 use as vector, 43:224-225 Hepatitis E, 39210, 221 Hepatitis E virus, 4057-59, 84-85, 94-Hepatitis viruses, diagnosis using syn-Hepatocarcinogenesis, HBV trans-activa-thetic peptides, 42:176-178 tors, 4R272-291 carboxy-terminally truncated HBV surface proteins, 47:286-289 cellular regulatory sequences as HBxmediated trans-activation target, Hepatocellular carcinoma, 4R269-272 cis (inkactivation of cellular genes, epidemiology, HBV-associated, 47:269hepatitis C virus and, 4081, 83 trans-activation of cellular gene ex-Hepatocyte nuclear factor 1, binding site, Herbal remedies, with Pluntugo spp., mechanism of transactivation of p T or late gene mRNA synthesis in, overview of, 37:87-88 structural and metabolic changes in cell nucleus after infection and, Herpes simplex virus type 2 cervical carcinoma induction, 32:285 inhibition by AAV in hamster cells, papilloma lesion conversion to carcicellular receptors for, 27185 classification, 44:358 cyclic and carbocyclic guanosine analog effect, 42:16-19 cyclopentenylcytosine effects, 42:ll-12 defective interfering viruses and, glycoproteins of, 33:31-32 HSV-1 glycoprotein D, vaccinia and, immunosorbent electron microscopy, induced apoptosis, 45:18-19 infection in AIDS patients, 43:108 manifestation in oral cavity, 42:218 penetration and uncoating of, 27185rapid enzyme immune filtration test, homology with MDV werotypes, latent in lymphoblastoid cell lines, during passages in cultured cells, Heterologous viruses, and HIV expres-Hexamethylene bis-acetamide, 43: 105 High-voltage electron microscopy Hit and run phenomenon, 31:358 HI test, torovirus, antibody detection, HIV, see Human immunodeficiency virus HM-L medium, 25207 Hodgkin's disease, human herpesvirus 6 pol gene products, 3924, 29, 31 positive-strand RNA viruses and, rotaviruses and, 39183, 185, 193, 199 satellite RNA for biocontrol and, Theiler's murine encephalomyelitis vitranslational suppression by retrovaccinia and, 3451 virus isolates, genetic relationships and, 25288 Honey bee viruses, host range, 31:301-Hop trefoil cryptic virus 41:148-150, 164, 167, 180, 182 H protein, 291 15, 323 HSB-2 cells, human herpesvirus 6, 41:21, HSV, see Herpes simplex virus HTLV, see Human T-cell lymphotrophic Human, role in plant-virus transmission, Human B-lymphotropic virus, 41:3 Human endogenous retroviruses, 41:144 Human foamy virus, 46100 Human growth hormone, neurodegenera-animal cells and, 36111-112, 126, 135 antigenic viral products, 42:114 and bacillary epithelioid angiomatosis, cellular responses, 42:125-127 CTLs, 42125-127 defective interfering viruses and, diagnosis using synthetic peptides, surface interactions with target cells, T-cell apoptosis, 4545-47 time course of immunobiological retranslational suppression by retro-CD4 receptor, expression and tropism, SIV model, 42:139 systemic immunity, 42132, 135-136 target organ immunity, 42132 variants in the virus, 42:107 in benign lesions and tumors, 37:130, carcinomas and, 37125-161 DNA fragment integration in cervical carcinomas, M325-327 DNA replication in, 37:140-141 early observations on, 37:126 E4 gene product in, 37:141-142 gene expression regulation, 37139-Theiler's murine encephalomyelitis vi-3210 rus and, 39311 Human rhinoviruses, animal cells and, Human T-cell leukemia virus receptor, Human T-cell leukemia virus types I 43: 15 1 -155 future research directions, 43:171genetic heterogeneity, 43:155-162 174 gag and enu epitope conservation, geographic-specific genotypes, interfamilial and intrafamilial se-Human T-cell lymphotrophic virus phylogenetic trees, 43:165-167, place diseases, 43147-148 prevalence in Japanese migrants in as privileged markers of migration of type I (cont. ) 4R406 as privileged markers of migration of ancient human populations, Human T-cell lymphotrophic virus type Husbandry, ASF and, 35256 HVT, see Herpesvirus of turkeys Hybrid dysgenesis, Drosophila retro-Hybridization, see also In situ hybridiza-(S)-l-(3-Hydroxy-2-phosphonylmethoxy-Hygromycin B, antiviral activity, 30111 Hypermutation, defective interfering vi-MAb-determined antigenic properties,",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "Insulin receptor, homology with ros gene Epstein-Barr virus and, 4033 hepatitis C virus and, 4081 Liver disease, hepatitis C virus and, Methoxymethyl-2'-deoxyuridine, anti-N-Methybaspartate receptor, rabies vi-",
            "latex": null,
            "type": "table"
        },
        "TABREF9": {
            "text": "Mycobacterium, oral vaccination and,",
            "latex": null,
            "type": "table"
        },
        "TABREF10": {
            "text": "Phaseolus, plant viruses in developing",
            "latex": null,
            "type": "table"
        },
        "TABREF25": {
            "text": "as structural component of prion, SDS, cucumber mosaic virus, 41:290 cucumber mosaic virus, 41:286 HEF glycoprotein of influenza C virus, simian hemorrhagic fever virus, activating compounds, HIV expression, in signal transduction from plasma Sedimentation coefficient, poliovirus vi-Seed banks, plant viruses in developing Seed-borne viruses, in developing countries crop improvement, 41:368-372 remedial action, 41:390-392, 394 cucumber mosaic virus, 41:331-332 plant viruses in developing countries, Semiautomated fluorometric assay, ASF, Semliki Forest virus, 33:331; 42:270-C6/36 cells infected by, fusion a t low components, synthesis, 38356-359 demyelination mechanisms, 42274 disturbance of blood-brain barrier, fusogenic protein, identification, humoral and cellular immunity, 42:273 inflammatory neuropathology, 43:273intraperitoneal infection, 42272 6K protein role in replication, 45:89lactate dehydrogenase-elevating virus, HN protein, hemagglutination and influenza virus, 34:270 in persistently infected cells, 29:113 protein, functional areas, 29107 transcription, 39141-142, 144, 147-Sensitivity, plant viruses in developing Sequence homology, potyvirus coat pro-virus-host plant relationships, virus-vector relationships, 41:333defective interfering viruses, 40182, animals and humans, 40196-197 plants, 40199-202, 204-205 Epstein-Barr virus, 4028, 30, 37-38, HEF glycoprotein of influenza C virus, hepatitis A virus, 39210 hepatitis C virus HIV-1,402-3,6-7,ll-12 gag gene products, 3919-20, 22 glycoproteins, 3940, 42-43, 47, 49 pol gene products, 3924, 29, 31-32, oncodna viruses, 39104, 106, 109-111 oral vaccination, 41:412-413, 425, 428, picornaviral genomes, 40158-161 positive-strand RNA viruses, 41:100, 182 common properties, 41:181 equine arteritis virus, 41:164-168 lactate dehydrogenase-elevating virus, 41:129, 144, 146, 148-150, 153 simian hemorrhagic fever virus, 41:178-179 rotaviruses, 39193, 199 satellite RNA for biocontrol, 39:321 Theiler's murine encephalomyelitis virus, 39296, 309, 311 translational suppression by retroviruses, 41:194, 196-197 readthrough suppression, 41:198-Sequence-specific methylation, adenovirus, 39:94-95, 111-114 eukaryotic promoters, 39:122-123 in uitro methylation, 39114-117 promoter inactivation, 39123-124 reversal of inhibition, 39117-119 spreading, 39119-122 DNA replication, 343-4, 17 phosphorylation, by protein kinase C, ADRV, 35210,212-213 human herpesvirus 6, 41:27-28 pestiviruses, 41:59 Serological differentiatiation indices, cucumber mosaic virus, 41:292, 294, 296 Serological specificity, bipartite genome of dianthoviruses, 33:283, 285 Shigella flexneri, 29:301, 305 Shigella sonnei, 29301, 304-305 Shipping fever, bovine herpesvirus role, Sialic acid oral vaccination, 41:414-415, 431 45204-206 animal cells, 36:112-113, 116, 127 HEF glycoprotein of influenza C virus, src oncogene family in, 37:lO-13 regulation by interferons, 42:73-78 Simian agent 12 virus, taxonomic poly-Simian hemorrhagic fever virus, 41:lOO-Simian rotavirus, 39:187 pression by, 41:228 mutants, 39172, 174, 177-179 reassortment, 39 170-17 1 studies, 39182-183, 185-186 Simian T lymphotropic virus mutant restricted in vertebrate cells, ORFs, 44:98-101 protection, MAb role, 29121 protein, functional areas, 29:107 replication in mosquito Societal factors, in regard to new, emerging, and reemerging diseases, 43:23-26 Sodium butyrate, 43:104-105 Sodium chloride, archaebacterial viruses, Sodium deoxycholate, 29:282 Sodium ions, viral infections, 33:192-193 Soil, transmission of dianthoviruses, Soil-borne viruses, plant viruses in devel-Soil-borne wheat mosaic virus, 361-3, Solanum, plant viruses in developing Solid-phase immunoassays, synthetic countries, 41:368-369, 384 peptides, 42:156-157 advantages and disadvantages, 4 2 150-15 1 Solid-phase radioimmunoassay, 29:170, 188, 193 diagnosis of SMV, 29:161-162 Somatic cell hybridization, 29132 Sorrel, wound tumor virus-infected, root Spl, role in HIV transcription, 43:65-67 breeding for resistance, 31:417 chemical applications, 31:419-421 reduction of landing sites, 31:418-419 environmental effect, 31:398-400 forms of, 31:409-417 spatial, 31:410-413 temporal, 31:410-412 models for description of, 31:413dependent on number of aphids, in soybeans, 31:416-417 role of sources in, 31:390-392 Spumavirus, and HIV expression, Squamous cell carcinoma cell line, Ep-Squash leaf curl virus, ultrastructure, 43:114-115 stein-Barr virus, 40:35 Staphylococcus aureus, influenza virus, Stellaria media, cucumber mosaic virus, STLV, see Simian T lymphotropic virus Stomach lining, types of glands, 42:219 Stool samples, ADRV, 35206-207 Strawberry green petal, Plantago hosts Streptococcal disease, group A, 43:39-40 and occurrence, 27: 116 Streptococcus mutans, oral vaccination, Streptococcus pyogenes M protein, oral Streptomyces, antibiotic production, Streptomycin, sensitivity to vibriocin, Subterranean clover red leaf virus, viruses, see Translational suppression by retroviruses Suppressor cells, viral infection, 35231 Surface immunoglobulin, Epstein-Barr Surface markers, and HIV expression, Surface projections, on viruses, 27:9-11 Surface proteins virus, 4020-21, 23 43:99-102 carboxy-terminally truncated hepatitis functional trans-activator domain, mechanisms of trans-activation, structural characterization, 47:287 target sequence of trans-activation, B virus, 4R286-289 simian hemorrhagic fever virus, varietal, to banana bunchy top virus, Swine, Japanese encephalitis infections, Swine fever, classical, see Classical human parvovirus B19 diagnosis, human T-cell leukemia virus diagmapping of epitopes by overlapping picornavirus diagnosis, 42168-169 prediction of continuous epitopes, respiratory syncytial virus diagnosis, solid-phase immunoassays, 42:156-157 synthesis, 4 2 15 1 -152 CD8+, immunopathological lesions in-CD4+, immunopathological reactions involving, 47358-364 cytotoxic, see Cytotoxic T cells Epstein-Barr virus, 4021, 36 functions, viral infection, 35231-232 helper, rotavirus-specific, 44177 hepadnavirus epitopes, 34:114, 127-129 pre-S sequences, 34:111-113 HIV-1, 401, 3-5, 9 HIV expression, 38126 HIV structure, 3944, 48 tat proteins, HIV structure, 39:11, lactate dehydrogenase-elevating virus age-dependent poliomyelitis, 41:129, mice, 41:112, 115, 117-121 140 lentiviruses, 34204 mature, activation-induced death, MBP-specific, 42295 oral vaccination, 41:411-412, 415-416 epitope presentation systems, 41:423, Temperature-gradient gel electro-Temperature-sensitive mutants persistent viruses, 2640 rotaviruses, 39:172-181, 195 phoresis, biocontrol, 39324-325 Temperature sensitivity, Sindbis virus, host range mutants, 33:343-345 Template switching model, illegitimate recombination, 43:292-293 Teratogenicity, rubella virus, 44:70-71 Terminal protein A, DNA replication, Termination codon, translational suppression by retroviruses, 41:210 Testis, abl genome, 355-52 Tetrahydroimidazo[4,5,l-jkl[ 1,4]benzodiazepin-2(1H)-one derivatives, see TIBO TFIIIC transcription factor, in truns-activation of transcription, 3761, 67 Theiler's murine encephalomyelitis virus, Theiler's viruses, picornaviruses, 36164-Thermolysin, tick-borne encephalitis vi-Thin sectioning of viruses, 2219-20 TIBO compounds, HIV structure, 3923-TIBO derivatives, 42:31-35 Tick-borne encephalitis virus, 2 9 1 h geographically defined variations, glycoprotein digestion, time course, in transport gene, 29:330-332 Plantago hosts and occurrence, 27:113, plant resistance to, 29251-252 positive hybridomas, 29139-142, 144 potyvirus coat protein, 36:278, 286gene functions, 38315-318 genes, see Genes, tobamovirus genomes 334 ability to manipulate, 38312-313 organization, 38308-312 identification, 31:322-323 MAb-determined antigenic properties, phenotype, effects of altered 30K protein production on, 38:334-335 Plantago hosts and occurrence, 2R113, potyvirus coat protein, 36287-288, proteins, translation after heat shock, protein synthesis, regulation, 38318-TobYDV, see Tobacco yellow dwarf virus Togaviruses, 41:146, 179-181 transport function, 38211-212 expanded, 28:205-207 Tomato golden mosaic virus genomic DNA, nucleotide sequence, MAb-determined antigenic properties, MAbs, 29135 Plantago hosts and occurrence, 27115, Tomato ringspot virus Tomato spotted wilt virus, 40241, 254, in developing countries, 41:374, 376, Plantago host and occurrence, 27:115 transport function complementation, Tomato yellow leafcurl virus, in develop-INDEX Tombusviridae (cont. ) TCV, 44:405-406 use as RNA vectors, M409 expression, 44:389-390 organization, 44:385-386, 419 22K and 19K proteins, functions, 33K and 92K proteins, functions, 41K protein, function, 44:392-395 noncoding regions, 44:396-399 defective interfering RNA (cont. ) host and host cell range, 43:238 immune response in infected host, infection routes, 43:258 isolation and growth in culture, 43237 morphology and morphogenesis, natural infection, 43:249-250 pathology and pathogenesis, 43:250persistence of infection in herd, physical and chemical properties, positive-strand RNA viruses, 41:146, protein composition and antigenic deseroepidemiology, 43255-256 susceptibility to environmental influtaxonomic relationship with coro-capsid protein as target of host decapsid protein phosphorylation, nucleotide phosphohydrolase, 43:327 RDRP domain, 43:325-327 RNA binding domain, 43:327 protozoal, 43:344-346 replication strategy and virion assemsatellite dsRNAs encoding killer toxins bly, 43:311-314 smut killer system, 43:356-360 yeast killer system, 43:347-356 satellite viruses, 43:305 taxonomy, 43:306-307 transmission, 43:332-334 viral proteins, 43:309 oligodeoxynucleotides, U 2 8 8 potential, antisense treatment, 44271 killer, Totivirus satellite dsRNA-ensmut killer system, 43:356-360 yeast killer system, 43347-356 Tracheobronchial epithelium, 42226 Trans-acting factors 4564-65 adenovirus, 39:94, 117, 123 picornaviral genomes, 40135-139, 150, 162 mRNA, 40131-135 RNA, 40:129-131 regulation by interferons, 42:78-81 translational suppression by retro-Trans-activation, translational, cau-Trans-activation of transcription, 37:35-37:51-53 viral, 37:70-74 Trans-activation region, HIV structure, Trans-activation response element, Transcription 396, 16,51-52 HIV-1, -104 adenovirus, 3991-93 control signals, 31:179-187 enhancer elements, 31:183-187 promoter sites, 31:179-183 E 1A protein-mediated activation, early, repression, 31:195-199 early to late transition, 31:199-204 late genes, activation of expression, INDEX Transcription (cont. ) adenovirus (cont. 1 Bunyaviridae, 40:252, 255-260, 264 bunyavirus S RNA, 31:40-41 cis-acting signals required for, Totiuirus, 43:319-320 cucumber mosaic virus, 41:309, 323-324 defective interfering viruses, 40184, intracellular cycles, 3660, 63, 67 organization, 3650-54 scattered repetition, 3641-44, 46 Epstein-Barr virus, 4048 89-91 EBNA-1,4041-42,44-47 EBNA-2,4028-30,32-34 genome, 4024, 26 equine arteritis virus, 41:158, 165hepatitis C virus, 4058, 72 hepatitis E virus, 4058, 89-90, 93 166 HIV-1, 402, 7-8, 10 HIV structure, 3 9 7 , 16, 35, 37, 51, 53human herpesvirus 6, 41:19 influenza virus, 34:248-249, 253, 255structural proteins, 34192-194 virus-host cell interaction in uiuo, virus-host cell interactions in uitro, neurodegenerative diseases caused by oral vaccination, 41:425, 434, 436-437 Paramyxoviridae, 39129, 133-135, genome organization, 39137-141 multiple entry of complex, 39145-RNA processing, 39142-144 single entry of complex, 39144-145 parvovirus genome, 33:117-119 pestiviruses, 41:77 phlebovirus S RNA, 31:40-42 picornaviral genomes, 40146-149 picornaviruses, 36170 poliovirus, 34219 rotaviruses, 3815-16; 39199 RSV RNA, 354-14 Sindbis virus encephalitis, 36263 spiroplasma virus, SpV4, 44:436-440 Theiler's murine encephalomyelitis vi-Transcriptional enhancer factor, pa-Transcriptional interference in ALV-induced B-cell lymphoma, SpV4, 44434 Transfer factor, in treatment of chickenribosomal frameshifting, 41:212, tRNAIdysJ primer, HIV-1 reverse tran-MoMLV lymphoid cells, 3544-45 oncogneic, parvovirus, 33:95-96 parvovirus infection, 33:168 viral, effect on cells, 2697-100 Transforming growth factor p, HIV expression inhibition, 43:119-120 Transforming growth factor pl, 42:363-364 Transforming growth factors, Ab-MLV, Transgenic mice, neurodegenerative diseases caused by prions, 41:259, 261-Transgenic plants, satellite RNA for bioadenovirus, 3999-100, 103, 115, 117 archaebacterial viruses, 34 18 1 -182 badnaviruses, M39-40 Bunyaviridae, 40:263 genome organization, 40243, 247, mechanism of synthesis of more 31:230-244 than one protein, 31:237-244 frameshifting during elongation, 31:243-244 initiation at other-than-AUG codons, 31:239-241 leaky scanning, 31:238-239 reinitiation, 31:241-243 suppression of terminator codon, 31:244 monocistronic nature, 31:235-237 in poliovirus-infected cells, and p220, 31:256, 264 cleavage and eIF-3 inactivation, specific early inhibition of host as subunit of cap binding factor,",
            "latex": null,
            "type": "table"
        },
        "TABREF26": {
            "text": "alphavirus glycoproteins, 331 1-12 influenza virus hemagglutinin, 336-7 rabies virus, 33:17-19 vesicular stomatitis virus, 33:17-19 Transmissible dementias, prions, 35124-Transmissible mink encephalopathy, ASF, 35255-256 cucumber mosaic virus, 41:284, 331, 333-335,337-338 filoviruses, 47:6, 14-15 human herpesvirus 6,41:28-29 iridoviruses, 46393-395 lactate dehydrogenase-elevating virus, 41:154-155, 157 neurodegenerative diseases caused by prions, 41:254-258, 262 plant viruses in developing countries Transmission crop improvement, 41:357, 367-368, remedial action, 41:381, 389 simian hemorrhagic fever virus, Transmission ecology, plant viruses, Transplantation, organ, and human her-Transport function, see also Plant virus-Transposons, analogy with avian retro-Trehalose dimycolate, 35302-303 Trichloroacetic acid, archaebacterial virus, 34179 Trichoderrna uiride, pectinase, 29219 Tricornaviruses cucumber mosaic virus, 41:302, 305, Tristeza, plant viruses in developing Triticurn aestivum, leaf protoplasts, virus Triton X-100, bacteriophage 46, 35144-Trophoblast interferon, 42:61 Tropical spastic paraparesis, 43:149-150 course of digestion with, 31:140 Tryptophan, translational suppression by T-suppressor cells, viral infection, 3523 1 Tuberculosis, 4338-39 Tubules, furoviruses, 3610 Tubulin, Paramyxoviridae, 39152 Tulip, plant viruses in developing coun-Tulip breaking virus, MAbs, 29:135 Tumor antigen, adenovirus, 25375-376 Tumor necrosis factor, HIV expression Tumor necrosis factor a, virus-infected Tumor necrosis factor receptor, Tumor regressor sera, Ab-MLV genome, Drosophilu retrotransposons, 3661 Epstein-Barr virus, 4020, 24, 34-36, human herpesvirus 6, 41:14, 34 initiation, wound tumor virus concen-lactate dehydrogenase-elevating virus, age-dependent poliomyelitis, 41:124 molecular properties, 41:150, 152-41:102, 117, 154-155 153 translational suppression by retrovirus detection in, 2240-42 cellular transforming genes, 22296herpesviruses as, 27:299-324 mechanisms of tumor production by, promoter insertion model, 22291-294 Bunyaviridae, 40247, 261 HEF glycoprotein of influenza C virus, hepadnavirus, 3498 Sindbis virus encephalitis, 36260 viruses, 41:228 Turnip crinkle virus, 33:216; 40199-206; defective interfering RNA, M405-408 replication proteins, 42198 satellite RNA, M410-412 protoplast infection, 29227 replication, inhibition, 29524 replication proteins, 42195-196 RNA, in subliminal infection, 29347 29174-175, 183, 186 3'-tRNA-like structure, 47216 Plantago host and occurrence, 27:116, Tymovirus, 2545-47 129 Type B virus, characteristics, 25474-Type D oncovirus, characteristics, Epstein-Barr virus, 4031-32, 40 in gene products of src family, 32109-Ab-MLV, 3563-66 114 as cofactor for AIDS progression, cucumber mosaic virus, 41:290 effect on BMV replication, 29339 flavivirus translation, 3370-72 killed antiviral vaccines, 39258, 260parvovirus DNA replication, 33:152-Ultraviolet transcription, equine arteritis Uncoating, viral, in cell penetration,",
            "latex": null,
            "type": "table"
        },
        "TABREF27": {
            "text": "inhibitors of, 27:163-167 intermediates of, 27:161-163 sites for, 27:160-161 United States Department of Agriculture (USDA), plant viruses in developing countries, 41:364, 367, 371 U protein, virion, 44:244-245 Upstream reading frames, picornaviral genomes, 40107-108,149-151 Uridine, equine arteritis virus, 41:156, 158, 164 Urine, virus detection in, 27:26-27 USF-1 binding site, 43:72-73 Ustilago maydis, 43:356-360 Uukuniemivirus, 40251, 255-256, 260-Abl, Ab-MLV, 35~63-67 Vaccination, see also Immunization chicken, by MDV serotypes and HTV, 30:266-270 immune mechanism induction, equine arteritis virus, 41:160-163 hepatitis A virus, 39214 30266-268 active immunization, 39238-242 characterization, 39222, 224 passive immunization, 39237-238 replication in cell culture, 39227 gag gene products, 39:19, 21, 24 glycoproteins, 3940, 48-49 leukemic children, 28343-344 oral, with recombinant bacteria, see HIV structure, 393-5, 7, 56 maintaining cell-mediated immunity, memory T-cell responses, 46296primary cell-mediated immune reguinea pig model, 46303-306 long-term immunity, 46293 maintenance mechanisms, 46300memory T cells, 46:285-286, 290disease correlations with cell-mediated immunity, 46272-273 DNA, 3852-53 enzymes induced by, 3868-74 gene expression, 3875-86 gene sequences, 46:268-269 genomic organization, 38:54-57 glycoproteins induced by, 3863-68 and HIV expression, 43:111-112 human herpesvirus 6, 41:17 infection drug delivery for, 35305 peripheral blood cells in uitro, reexposure, maintaining cell-mediated restriction endonuclease maps, 3857structural proteins, 38:74-75 structure, 3851-52 subclinical viremia, relationship betropism, T lymphocytes, severe com-tween episodes, 46305 bined immunodeficient hu mouse, 46276-280 Vector cell, susceptibility, 25230-231 Vector cell lines 271 establishment, plant viruses, 45269-incidence, monitoring methods, landing traps, 31:404-405 sampling insects on vegetation, sticky traps, 31:402-403 suction traps, 31:403 vertical traps, 31:403 yellow water traps, 31:402 infection incidence, monitoring field, 31:408 use of bait plants for, 31:408-409 retention, 31:393 specificity, 31:393-394 crop improvement, 41:355, 357-359, Vicia cryptic virus, cellular location in Vicia faba, cucumber mosaic virus, HIV-1,40:12-13 vif protein, HIV structure, 3950, 55 Vigna sesquepedalis, leaf protoplasts, virus infection, 29228 Vigna sinensis unguicullata facultative resistance, 29340 resistance to viruses, 29339 virus infection, 29228 cell suspension, inoculation with TMV-Vinca rosea RNA, 29:239 auxin requirement, 29:224 isolation, 29225 cells, 32:1115 tiviral activity, 30103 Vinculin, alteration in RSV-transformed 5-Vinyl-lP-~-arabinofuranosyluracil, an-Viral a, synthesis, in HSV replication, Viral-bacterial synergistic interaction in 3R90-92 respiratory disease bacterial adherence, 35222-224 bacterial effects on host defense mechcontrol of, 35237-241 anisms, 35232-234 antiviral chemotherapy, 35239immunomodulators, 35241 virus vaccines, 35238-239 general considerations for, 35:219-220, immunopathology, 35236-237 predisposing factors, 35234-236 Viral-bacterial synergy, bovine her-Viral coat protein genes, in viral trans-Viral-coded trans-activator, RSV RNA, mouse hepatitis virus, 42261-265 Semliki Forest virus, 42270-275 Theiler's virus, 42266-270 visna virus, 42275-278 autoimmune mechanisms, 42294-296 autoreactivity to CNS antigens, 42296 CNS structure and functional organization, 42252-256 cross-reactivity between viral and host cell proteins, 42296 demyelinating viruses, 42252 epidemics, 42:289 expression of viral proteins, 42:292genetic control of immune response, HIV, 42284-285 HTLV-I-associated, 42:286 initiation of infection, a 2 8 9 mechanisms, 42291-296 multiple sclerosis, 42:286 mutations in RNA genomes, 42:288 postinfectious encephalomyelitis, progressive multifocal leukoensubacute sclerosing panencephalitis, viral-specific T-cell destruction, 42293-294 virus and host genetics, 42286-291 Viral diagnosis, 27:l-69 Viral diseases, transmission by arthropod Viral DNA, replication, 37:102-112 Viral erbB gene, in signal transduction, Viral HSV DNA polymerase, properties, Viral infection, see also Antisense treatacute and persistent, immunological memory impairment, 4547 adeno-associated virus, 25418-420 apoptosis mediated by B cells, 4530cell lysis by TNF-a, 4528-30 effect on target susceptibility to CTLmediated DNA fragmentation, Viral oncogenicity, adenovirus, 25436-Viral penetration stages, 27:143-167, 27: 19 1 -192 endocytosis, 27:151-154 fusion, 27:154-159 herpesviruses, 27: 185-187 orthomyxoviruses, 27:167-174 papovaviruses, 27192-195 paramyxoviruses, 27:175-176 picornaviruses, 27187-189 reoviruses, 27: 189-19 1 retroviruses, 27: 182-185 rhabdoviruses, 27178-180 togaviruses, 27:181-182 Viral persistence, 46:313-339 virus-induced changes in cells, 46316-321 virus-induced alterations, host cellular differentiated functions in absence of cytolysis, 46323-338 experimental evidence, 46:323-324 growth hormone deficiency synneuroendocrine dysfunctions, viral interactions with cytoskeleton, Viral protein 1, Theiler's murine virus, conformational changes and complex essential for PRDl DNA replication, HSV DNA replication formation, 29:116-118 45303-304 organization in nucleus, 37108-111 properties, 37104-106 maturation, 29:115-116 Viral satellites, symptoms of infection, Viral strains, banana bunchy top virus, Viral suspension, killed antiviral vac-Viral trans-activation of cellular tran-cines, 39265-266, 268, 270, 283 scription, 37:70, 74 by arthropods, 43:13 pararetroviruses and retroviruses, 44: 1 1-13 Viral vectors gene replacement therapy, 47:303-304 as probes, 47:304 hepatitis A virus, 39219 lactate dehydrogenase-elevating virus, envelope antigens, methods for studyequine arteritis virus, 41:156, 161, inoculum, minimal concentration, in uitro properties, 25:142-144 iridoviruses, packaging, 46:382-383 lactate dehydrogenase-elevating virus age-dependent poliomyelitis, 41:127 mice, 41:104, 112, 123-124 molecular properties, 41:144-150 Totiuirus, replication strategy, 43:311-Virion precipitation test, envelope anti-Virion proteins, human herpesvirus 6, plant cell culture infection with, possible animal-type, 28:276-277 possible origin, 28273-276 propagation, 28249-250 protoplast infection with, 29241-242 purification, 28252 replication mechanism, 28:261-273 Virus-associated RNA, adenovirus, Virus binding site, Totzuirus, 43:315-317 Virus clearance, simian hemorrhagic fe-Virus ecology, plant viruses in develop-Viruses, see also Nonpersistent viruses; ver virus, 41:176-178 ing countries, 41:349, 351 Plant viruses antibody detection, 2R51-53 architecture, 29:117-118 examination, 29117 arthropod transmission, 43:13 specificity, 33328 attachment proteins, 27:148-150 bacteriophage relationship to, 27254in cell cultures 260 mammals compared to, 26:42-47 persistence, 2638-42 cell lines, susceptibilities of, 25229 cells infected by, antigen reexpression cell transformation by, 2697-100 cellular receptors, 27:143-148 chemoprophylaxis, 2647-49 chemotherapy, 2637-64 with continuous (unipartite) genome, defense against, interferon system, as differentiation probes, 26:65-116 INDEX Viruses (cont. ) effect on stem cell development, entry into epithelial cell lines, 42:198-100 gene organization in, 26100-105 genetic material, penetration into host genetic organization, 27256 genitourinary tract, 42:230-232 glassware, adsorption on, 25254 glycoproteins, functions, 33:l heterologous, and HIV expression, identification, MAbs in, 29:99-104 inocula, storage a t low temperatures, insect, physical properties, 25286 interaction with host, questions conlatency, tissue tropisms, 2669-72 local or systemic infections, polarized epithelial cell role, 42:209-211 as macromolecular assemblies, 28176-185 in mammals, 2642-47 morphology, 27:2-14 with multipartite genome, 2548-68 mutations, 29118 negative staining, 27:15-16 neutralization on vector cell mono-as chemotherapy models, 26:37-64 immunopathogenic mechanisms, 2645-47 stages, 2641-42 Plantago, 2 7 103-140 list, 27:112-116 plant interactions with, 26201-237 polarity and pathogenesis, 42207-209 prions us., 3585-87 protection with MAbs, 29121-122 with protein-dependent tripartite genome, 2548-54 with protein-independent tripartite genome, 2554-58 purification, 25223-224 release from polarized epithelial cells, replication, regulation by defective viruses, 2645 retroid, 32:35-87 role in infection 42199-205 alteration in course of, 29:120-121 host range mutants restricted in Aedes albopictus, 33343-347 mutant replication in methioninestarved Aedes albopictus cells, 33:358-362 cells, 33:348-358 seroidentification, 2751 specific infectivities, 25217-219 with surface projections, 279-11 thin sectioning, 27:19-20 transformation-specific proteins, transmissibility, loss, vector, 25:217 transmission by vectors, infectivity to, tumor-causing, see Tumor viruses variants mutants restricted to vertebrate isolation, 2 9 1 19-120 MAb selection, 29110 vector cell monlayer, 25198-200 wild-type, see Wild-type viruses Virus-host recognition, early events in, Virus-induced proteins, 29332 Virus-like particles transcription, 3675 formation by retroviruses and parahepatitis C virus, 4078 hepatitis E virus, 4087 retroviruses, 44:5 1-52 Virus-neutralizing antibodies, oral vac-Virus-specific proteins, 29322 Virus-specific ribonucleoprotein parti-Virus strain, effect on transmissibility, Virus structure, 28175-240 cles, 29:314 25:124-126 assemblies and symmetry in, 28181 helical symmetry in, 28181 icosahedral designs in, 28213-219 icosahedral symmetry in, 28183nucleoprotein rods and shells in, viral membrane role, 28219-235 Virus theory, 43:43 Virus-vector relationship, 25:120-122 kit gene in signal transduction, 37:6 VP4, viral hemagglutinin, in rotavirus, VP6 protein, in single-shelled rotavirus HIV-1,4012-14 HIV structure, 3950, 55 VP-1IVP-2 genes, parvoviruses, functions, genetic analysis, 38436-439 vpx protein, HIV structure, 3950 V-re1 oncogene, in signal transduction, vRNP, as possible element of transport u-sis, as growth factor, 37:4 Vulnerability, plant viruses in develop-3717-18 function, 38241 ing countries, 41:379, 397 Warts, papillomavirus, 37:128, 130 Wasp viruses, and virus-like particles, Wasting syndrome, 46:333 Water-borne hepatitis, 39210, 222, 236-237 Watermelon mosaic virus-11, potyvirus coat protein, 36276, 292, 305 WCCV, see White clover cryptic virus Weeds cucumber mosaic virus, 41:336-337 Pluntugo spp. as, 27:108-109 plant viruses in developing countries, Zea mays, leaf protoplasts, virus infec-Zinc levels, bacterial adherence, 35:223 Zinga virus, study, MAbs in, %lo3 Zonula adherens, 42:191-192 Zonula occludens, 42:190-191 Zucchini yellow mosaic virus in developing countries, 41:371, 377",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": " 210, 233 alternate stop codons, ",
            "cite_spans": [
                {
                    "start": 1,
                    "end": 5,
                    "text": "210,",
                    "ref_id": null
                },
                {
                    "start": 6,
                    "end": 32,
                    "text": "233 alternate stop codons,",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}